InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Petree Daniel H, Director. Director active across 1 companies, notably Sutro Biopharma, INC.. Cumulatively, 2 reports have been published. The latest transaction was filed on 8 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€17,3174,545 shares@ €3.81020.0027% mcap100.0% of flow
Common Stock
SEC:0001209191-22-008198·
€17,3174,545 shares@ €3.81020.0027% mcap50.0% of flow
Common Stock
SEC:0001209191-22-008198:0·
2 of 2 declarations
About Petree Daniel H
Daniel H. Petree is a Director at SUTRO BIOPHARMA, INC., a biotechnology company. As a director, he contributes to the governance of the company and to strategic decision-making. His experience in the biotechnology field is an asset for SUTRO.
